Stojmenović, Tamara

Link to this page

Authority KeyName Variants
b26fd9db-68a8-4225-8acd-bfffadbb1aa6
  • Stojmenović, Tamara (9)
Projects

Author's Bibliography

Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial

Michalickova, Danica; Kostić-Vučićević, Marija; Vukašinović-Vesić, Milica; Stojmenović, Tamara; Dikić, Nenad; Anđelković, Marija; Đorđević, Brižita; Tanasković, Bojana P.; Minić, Rajna

(Lippincott Williams & Wilkins, Philadelphia, 2017)

TY  - JOUR
AU  - Michalickova, Danica
AU  - Kostić-Vučićević, Marija
AU  - Vukašinović-Vesić, Milica
AU  - Stojmenović, Tamara
AU  - Dikić, Nenad
AU  - Anđelković, Marija
AU  - Đorđević, Brižita
AU  - Tanasković, Bojana P.
AU  - Minić, Rajna
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2955
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3440
AB  - To test the influence of probiotic supplementation on humoral immune response, a double-blind, placebo-controlled trial was conducted. Thirty athletes (24 males and 6 females, females: (V)over dotO(2)max 38.2 +/- 4.9 ml.kg(-1).min(-1), age 23.2 +/- 1.4 years; males: (V)over dotO(2)max 57.5 +/- 9.2 ml.kg(-1).min(-1), age 24.0 +/- 2.4 years, mean +/- SD) were randomized either to the probiotic group (Lactobacillus helveticus Lafti L10, 2 x 10(10) colony-forming units) or to the placebo group. Serum and saliva samples were collected at the baseline and after 14 weeks. Total and specific antibacterial antibody levels of IgM, IgG, and IgA classes were determined for different bacteria in the serum, and in saliva, total and specific antibacterial IgA levels were examined. Total IgM was elevated in both probiotic (18%, 15-20%; mean, 90% confidence interval; p = 0.02) and placebo group (35%, 22-47%; p = 0.02), without observed differences in changes between the groups. No significant changes in IgM levels specific for tested bacteria were found. Total IgG level was constant in both groups. A significant (16%, 22.8 to 35%, p = 0.04) reduction of anti-Enterococcus faecalis IgG was noted in the placebo group, in comparison with the probiotic group. There was a substantial decrease in total IgA level in the placebo group, when measured either in serum (15%, 12-18%, p = 0.04) or in saliva (35%, -1.4 to 53%, p = 0.03). Significantly reduced levels of serum anti-lactic acid bacteria IgA antibodies in the placebo group compared with the probiotic group were detected for Lactobacillus rhamnosus LA68 (24%, 5.8-42%, p = 0.02) and for L. rhamnosus LB64 (15%, 2.7-27%, p = 0.02). Probiotic administration could have beneficial effects on systemic humoral and mucosal immune responses.
PB  - Lippincott Williams & Wilkins, Philadelphia
T2  - Journal of Strength and Conditioning Research
T1  - Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial
VL  - 31
IS  - 1
SP  - 62
EP  - 70
DO  - 10.1519/JSC.0000000000001456
ER  - 
@article{
author = "Michalickova, Danica and Kostić-Vučićević, Marija and Vukašinović-Vesić, Milica and Stojmenović, Tamara and Dikić, Nenad and Anđelković, Marija and Đorđević, Brižita and Tanasković, Bojana P. and Minić, Rajna",
year = "2017",
abstract = "To test the influence of probiotic supplementation on humoral immune response, a double-blind, placebo-controlled trial was conducted. Thirty athletes (24 males and 6 females, females: (V)over dotO(2)max 38.2 +/- 4.9 ml.kg(-1).min(-1), age 23.2 +/- 1.4 years; males: (V)over dotO(2)max 57.5 +/- 9.2 ml.kg(-1).min(-1), age 24.0 +/- 2.4 years, mean +/- SD) were randomized either to the probiotic group (Lactobacillus helveticus Lafti L10, 2 x 10(10) colony-forming units) or to the placebo group. Serum and saliva samples were collected at the baseline and after 14 weeks. Total and specific antibacterial antibody levels of IgM, IgG, and IgA classes were determined for different bacteria in the serum, and in saliva, total and specific antibacterial IgA levels were examined. Total IgM was elevated in both probiotic (18%, 15-20%; mean, 90% confidence interval; p = 0.02) and placebo group (35%, 22-47%; p = 0.02), without observed differences in changes between the groups. No significant changes in IgM levels specific for tested bacteria were found. Total IgG level was constant in both groups. A significant (16%, 22.8 to 35%, p = 0.04) reduction of anti-Enterococcus faecalis IgG was noted in the placebo group, in comparison with the probiotic group. There was a substantial decrease in total IgA level in the placebo group, when measured either in serum (15%, 12-18%, p = 0.04) or in saliva (35%, -1.4 to 53%, p = 0.03). Significantly reduced levels of serum anti-lactic acid bacteria IgA antibodies in the placebo group compared with the probiotic group were detected for Lactobacillus rhamnosus LA68 (24%, 5.8-42%, p = 0.02) and for L. rhamnosus LB64 (15%, 2.7-27%, p = 0.02). Probiotic administration could have beneficial effects on systemic humoral and mucosal immune responses.",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Journal of Strength and Conditioning Research",
title = "Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial",
volume = "31",
number = "1",
pages = "62-70",
doi = "10.1519/JSC.0000000000001456"
}
Michalickova, D., Kostić-Vučićević, M., Vukašinović-Vesić, M., Stojmenović, T., Dikić, N., Anđelković, M., Đorđević, B., Tanasković, B. P.,& Minić, R.. (2017). Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial. in Journal of Strength and Conditioning Research
Lippincott Williams & Wilkins, Philadelphia., 31(1), 62-70.
https://doi.org/10.1519/JSC.0000000000001456
Michalickova D, Kostić-Vučićević M, Vukašinović-Vesić M, Stojmenović T, Dikić N, Anđelković M, Đorđević B, Tanasković BP, Minić R. Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial. in Journal of Strength and Conditioning Research. 2017;31(1):62-70.
doi:10.1519/JSC.0000000000001456 .
Michalickova, Danica, Kostić-Vučićević, Marija, Vukašinović-Vesić, Milica, Stojmenović, Tamara, Dikić, Nenad, Anđelković, Marija, Đorđević, Brižita, Tanasković, Bojana P., Minić, Rajna, "Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial" in Journal of Strength and Conditioning Research, 31, no. 1 (2017):62-70,
https://doi.org/10.1519/JSC.0000000000001456 . .
19
21
15
23

Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial

Michalickova, Danica; Kostić-Vučićević, Marija; Vukašinović-Vesić, Milica; Stojmenović, Tamara; Dikić, Nenad; Anđelković, Marija; Đorđević, Brižita; Tanasković, Bojana P.; Minić, Rajna

(Lippincott Williams & Wilkins, Philadelphia, 2017)

TY  - JOUR
AU  - Michalickova, Danica
AU  - Kostić-Vučićević, Marija
AU  - Vukašinović-Vesić, Milica
AU  - Stojmenović, Tamara
AU  - Dikić, Nenad
AU  - Anđelković, Marija
AU  - Đorđević, Brižita
AU  - Tanasković, Bojana P.
AU  - Minić, Rajna
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2955
AB  - To test the influence of probiotic supplementation on humoral immune response, a double-blind, placebo-controlled trial was conducted. Thirty athletes (24 males and 6 females, females: (V)over dotO(2)max 38.2 +/- 4.9 ml.kg(-1).min(-1), age 23.2 +/- 1.4 years; males: (V)over dotO(2)max 57.5 +/- 9.2 ml.kg(-1).min(-1), age 24.0 +/- 2.4 years, mean +/- SD) were randomized either to the probiotic group (Lactobacillus helveticus Lafti L10, 2 x 10(10) colony-forming units) or to the placebo group. Serum and saliva samples were collected at the baseline and after 14 weeks. Total and specific antibacterial antibody levels of IgM, IgG, and IgA classes were determined for different bacteria in the serum, and in saliva, total and specific antibacterial IgA levels were examined. Total IgM was elevated in both probiotic (18%, 15-20%; mean, 90% confidence interval; p = 0.02) and placebo group (35%, 22-47%; p = 0.02), without observed differences in changes between the groups. No significant changes in IgM levels specific for tested bacteria were found. Total IgG level was constant in both groups. A significant (16%, 22.8 to 35%, p = 0.04) reduction of anti-Enterococcus faecalis IgG was noted in the placebo group, in comparison with the probiotic group. There was a substantial decrease in total IgA level in the placebo group, when measured either in serum (15%, 12-18%, p = 0.04) or in saliva (35%, -1.4 to 53%, p = 0.03). Significantly reduced levels of serum anti-lactic acid bacteria IgA antibodies in the placebo group compared with the probiotic group were detected for Lactobacillus rhamnosus LA68 (24%, 5.8-42%, p = 0.02) and for L. rhamnosus LB64 (15%, 2.7-27%, p = 0.02). Probiotic administration could have beneficial effects on systemic humoral and mucosal immune responses.
PB  - Lippincott Williams & Wilkins, Philadelphia
T2  - Journal of Strength and Conditioning Research
T1  - Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial
VL  - 31
IS  - 1
SP  - 62
EP  - 70
DO  - 10.1519/JSC.0000000000001456
ER  - 
@article{
author = "Michalickova, Danica and Kostić-Vučićević, Marija and Vukašinović-Vesić, Milica and Stojmenović, Tamara and Dikić, Nenad and Anđelković, Marija and Đorđević, Brižita and Tanasković, Bojana P. and Minić, Rajna",
year = "2017",
abstract = "To test the influence of probiotic supplementation on humoral immune response, a double-blind, placebo-controlled trial was conducted. Thirty athletes (24 males and 6 females, females: (V)over dotO(2)max 38.2 +/- 4.9 ml.kg(-1).min(-1), age 23.2 +/- 1.4 years; males: (V)over dotO(2)max 57.5 +/- 9.2 ml.kg(-1).min(-1), age 24.0 +/- 2.4 years, mean +/- SD) were randomized either to the probiotic group (Lactobacillus helveticus Lafti L10, 2 x 10(10) colony-forming units) or to the placebo group. Serum and saliva samples were collected at the baseline and after 14 weeks. Total and specific antibacterial antibody levels of IgM, IgG, and IgA classes were determined for different bacteria in the serum, and in saliva, total and specific antibacterial IgA levels were examined. Total IgM was elevated in both probiotic (18%, 15-20%; mean, 90% confidence interval; p = 0.02) and placebo group (35%, 22-47%; p = 0.02), without observed differences in changes between the groups. No significant changes in IgM levels specific for tested bacteria were found. Total IgG level was constant in both groups. A significant (16%, 22.8 to 35%, p = 0.04) reduction of anti-Enterococcus faecalis IgG was noted in the placebo group, in comparison with the probiotic group. There was a substantial decrease in total IgA level in the placebo group, when measured either in serum (15%, 12-18%, p = 0.04) or in saliva (35%, -1.4 to 53%, p = 0.03). Significantly reduced levels of serum anti-lactic acid bacteria IgA antibodies in the placebo group compared with the probiotic group were detected for Lactobacillus rhamnosus LA68 (24%, 5.8-42%, p = 0.02) and for L. rhamnosus LB64 (15%, 2.7-27%, p = 0.02). Probiotic administration could have beneficial effects on systemic humoral and mucosal immune responses.",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Journal of Strength and Conditioning Research",
title = "Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial",
volume = "31",
number = "1",
pages = "62-70",
doi = "10.1519/JSC.0000000000001456"
}
Michalickova, D., Kostić-Vučićević, M., Vukašinović-Vesić, M., Stojmenović, T., Dikić, N., Anđelković, M., Đorđević, B., Tanasković, B. P.,& Minić, R.. (2017). Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial. in Journal of Strength and Conditioning Research
Lippincott Williams & Wilkins, Philadelphia., 31(1), 62-70.
https://doi.org/10.1519/JSC.0000000000001456
Michalickova D, Kostić-Vučićević M, Vukašinović-Vesić M, Stojmenović T, Dikić N, Anđelković M, Đorđević B, Tanasković BP, Minić R. Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial. in Journal of Strength and Conditioning Research. 2017;31(1):62-70.
doi:10.1519/JSC.0000000000001456 .
Michalickova, Danica, Kostić-Vučićević, Marija, Vukašinović-Vesić, Milica, Stojmenović, Tamara, Dikić, Nenad, Anđelković, Marija, Đorđević, Brižita, Tanasković, Bojana P., Minić, Rajna, "Lactobacillus helveticus lafti L10 supplementation modulates mucosal and humoral immunity in elite athletes: A randomized, double-blind, placebo-controlled trial" in Journal of Strength and Conditioning Research, 31, no. 1 (2017):62-70,
https://doi.org/10.1519/JSC.0000000000001456 . .
19
21
15
23

The Effect of Lactobacillus Helveticus L10 Supplementation on Respiratory Infections and Mucosal Immunity in Elite Athletes

Marinković, Danica; Minić, Rajna; Dikić, Nenad; Anđelković, Marija; Vukašinović-Vesić, Milica; Kostić-Vučićević, Marija; Stojmenović, Tamara; Nikolić, Ivan; Đorđević, Brižita

(Lippincott Williams & Wilkins, Philadelphia, 2016)

TY  - CONF
AU  - Marinković, Danica
AU  - Minić, Rajna
AU  - Dikić, Nenad
AU  - Anđelković, Marija
AU  - Vukašinović-Vesić, Milica
AU  - Kostić-Vučićević, Marija
AU  - Stojmenović, Tamara
AU  - Nikolić, Ivan
AU  - Đorđević, Brižita
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2637
PB  - Lippincott Williams & Wilkins, Philadelphia
C3  - Journal of Clinical Gastroenterology
T1  - The Effect of Lactobacillus Helveticus L10 Supplementation on Respiratory Infections and Mucosal Immunity in Elite Athletes
VL  - 50
IS  - Supplement 2
SP  - S227
EP  - S228
DO  - 10.1097/MCG.0000000000000691
ER  - 
@conference{
author = "Marinković, Danica and Minić, Rajna and Dikić, Nenad and Anđelković, Marija and Vukašinović-Vesić, Milica and Kostić-Vučićević, Marija and Stojmenović, Tamara and Nikolić, Ivan and Đorđević, Brižita",
year = "2016",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Journal of Clinical Gastroenterology",
title = "The Effect of Lactobacillus Helveticus L10 Supplementation on Respiratory Infections and Mucosal Immunity in Elite Athletes",
volume = "50",
number = "Supplement 2",
pages = "S227-S228",
doi = "10.1097/MCG.0000000000000691"
}
Marinković, D., Minić, R., Dikić, N., Anđelković, M., Vukašinović-Vesić, M., Kostić-Vučićević, M., Stojmenović, T., Nikolić, I.,& Đorđević, B.. (2016). The Effect of Lactobacillus Helveticus L10 Supplementation on Respiratory Infections and Mucosal Immunity in Elite Athletes. in Journal of Clinical Gastroenterology
Lippincott Williams & Wilkins, Philadelphia., 50(Supplement 2), S227-S228.
https://doi.org/10.1097/MCG.0000000000000691
Marinković D, Minić R, Dikić N, Anđelković M, Vukašinović-Vesić M, Kostić-Vučićević M, Stojmenović T, Nikolić I, Đorđević B. The Effect of Lactobacillus Helveticus L10 Supplementation on Respiratory Infections and Mucosal Immunity in Elite Athletes. in Journal of Clinical Gastroenterology. 2016;50(Supplement 2):S227-S228.
doi:10.1097/MCG.0000000000000691 .
Marinković, Danica, Minić, Rajna, Dikić, Nenad, Anđelković, Marija, Vukašinović-Vesić, Milica, Kostić-Vučićević, Marija, Stojmenović, Tamara, Nikolić, Ivan, Đorđević, Brižita, "The Effect of Lactobacillus Helveticus L10 Supplementation on Respiratory Infections and Mucosal Immunity in Elite Athletes" in Journal of Clinical Gastroenterology, 50, no. Supplement 2 (2016):S227-S228,
https://doi.org/10.1097/MCG.0000000000000691 . .

Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial

Michalickova, Danica; Minić, Rajna; Dikić, Nenad; Anđelković, Marija; Kostić-Vučićević, Marija; Stojmenović, Tamara; Nikolić, Ivan; Đorđević, Brižita

(Canadian Science Publishing, Nrc Research Press, Ottawa, 2016)

TY  - JOUR
AU  - Michalickova, Danica
AU  - Minić, Rajna
AU  - Dikić, Nenad
AU  - Anđelković, Marija
AU  - Kostić-Vučićević, Marija
AU  - Stojmenović, Tamara
AU  - Nikolić, Ivan
AU  - Đorđević, Brižita
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3441
AB  - A randomized, double-blind, placebo-controlled study was conducted to evaluate if Lactobacillus helveticus Lafti L10 (Lallemand Health Solutions, Montreal, Que., Canada) supplementation during 14 weeks in winter can influence the duration, severity, and incidence of upper respiratory tract illness (URTI), as well as to monitor different immune parameters in the population of elite athletes. Before and after the treatment, cardiopulmonary testing and self-rated state of moods evaluation (by Profile of Mood States questionnaire) were performed and blood samples were collected. Thirty-nine elite athletes were randomized either to the placebo (n = 19) or the probiotic (n = 20) group. The probiotic group received L. helveticus Lafti L10, 2 x 10(10) Colony Forming Units. Lafti L10 significantly shortened the URTI episode duration (7.25 +/- 2.90 vs. 10.64 +/- 4.67 days, p = 0.047) and decreased the number of symptoms in the probiotic group (4.92 +/- 1.96 vs. 6.91 +/- 1.22, p = 0.035). Severity and incidence of URTI did not differ between the treatments. There were no significant changes in leukocyte subpopulation abundance, transforming growth factor-beta serum levels, level of interleukin-10 secreted from peptidoglican stimulated peripheral blood mononuclear cells (PBMCs), interferon-gamma level secreted from concanavalin A-stimulated PBMCs or viability/proliferation of PBMCs upon antigen stimulation. Group effect for CD4+/CD8+ ratio was significant (F-[1,F-37] = 6.99, p = 0.020, eta(2) = 0.350); this difference was not significant at baseline, but was evident after 14 weeks (p = 0.02). A significant interaction effect was noted for self-rated sense of vigor (F-[1,F-37] = 11.76, p = 0.009, eta(2) = 0.595). Self-rated sense of vigor increased in the probiotic group (18.5 +/- 4.1 vs. 21.0 +/- 2.6, p = 0.012). Probiotic strain Lafti L10 can be a beneficial nutritional supplement for the reduction of URTI length in elite athletes.
PB  - Canadian Science Publishing, Nrc Research Press, Ottawa
T2  - Applied Physiology Nutrition and Metabolism
T1  - Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial
VL  - 41
IS  - 7
SP  - 782
EP  - 789
DO  - 10.1139/apnm-2015-0541
ER  - 
@article{
author = "Michalickova, Danica and Minić, Rajna and Dikić, Nenad and Anđelković, Marija and Kostić-Vučićević, Marija and Stojmenović, Tamara and Nikolić, Ivan and Đorđević, Brižita",
year = "2016",
abstract = "A randomized, double-blind, placebo-controlled study was conducted to evaluate if Lactobacillus helveticus Lafti L10 (Lallemand Health Solutions, Montreal, Que., Canada) supplementation during 14 weeks in winter can influence the duration, severity, and incidence of upper respiratory tract illness (URTI), as well as to monitor different immune parameters in the population of elite athletes. Before and after the treatment, cardiopulmonary testing and self-rated state of moods evaluation (by Profile of Mood States questionnaire) were performed and blood samples were collected. Thirty-nine elite athletes were randomized either to the placebo (n = 19) or the probiotic (n = 20) group. The probiotic group received L. helveticus Lafti L10, 2 x 10(10) Colony Forming Units. Lafti L10 significantly shortened the URTI episode duration (7.25 +/- 2.90 vs. 10.64 +/- 4.67 days, p = 0.047) and decreased the number of symptoms in the probiotic group (4.92 +/- 1.96 vs. 6.91 +/- 1.22, p = 0.035). Severity and incidence of URTI did not differ between the treatments. There were no significant changes in leukocyte subpopulation abundance, transforming growth factor-beta serum levels, level of interleukin-10 secreted from peptidoglican stimulated peripheral blood mononuclear cells (PBMCs), interferon-gamma level secreted from concanavalin A-stimulated PBMCs or viability/proliferation of PBMCs upon antigen stimulation. Group effect for CD4+/CD8+ ratio was significant (F-[1,F-37] = 6.99, p = 0.020, eta(2) = 0.350); this difference was not significant at baseline, but was evident after 14 weeks (p = 0.02). A significant interaction effect was noted for self-rated sense of vigor (F-[1,F-37] = 11.76, p = 0.009, eta(2) = 0.595). Self-rated sense of vigor increased in the probiotic group (18.5 +/- 4.1 vs. 21.0 +/- 2.6, p = 0.012). Probiotic strain Lafti L10 can be a beneficial nutritional supplement for the reduction of URTI length in elite athletes.",
publisher = "Canadian Science Publishing, Nrc Research Press, Ottawa",
journal = "Applied Physiology Nutrition and Metabolism",
title = "Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial",
volume = "41",
number = "7",
pages = "782-789",
doi = "10.1139/apnm-2015-0541"
}
Michalickova, D., Minić, R., Dikić, N., Anđelković, M., Kostić-Vučićević, M., Stojmenović, T., Nikolić, I.,& Đorđević, B.. (2016). Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial. in Applied Physiology Nutrition and Metabolism
Canadian Science Publishing, Nrc Research Press, Ottawa., 41(7), 782-789.
https://doi.org/10.1139/apnm-2015-0541
Michalickova D, Minić R, Dikić N, Anđelković M, Kostić-Vučićević M, Stojmenović T, Nikolić I, Đorđević B. Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial. in Applied Physiology Nutrition and Metabolism. 2016;41(7):782-789.
doi:10.1139/apnm-2015-0541 .
Michalickova, Danica, Minić, Rajna, Dikić, Nenad, Anđelković, Marija, Kostić-Vučićević, Marija, Stojmenović, Tamara, Nikolić, Ivan, Đorđević, Brižita, "Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial" in Applied Physiology Nutrition and Metabolism, 41, no. 7 (2016):782-789,
https://doi.org/10.1139/apnm-2015-0541 . .
40
58
36
58

Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial

Michalickova, Danica; Minić, Rajna; Dikić, Nenad; Anđelković, Marija; Kostić-Vučićević, Marija; Stojmenović, Tamara; Nikolić, Ivan; Đorđević, Brižita

(Canadian Science Publishing, Nrc Research Press, Ottawa, 2016)

TY  - JOUR
AU  - Michalickova, Danica
AU  - Minić, Rajna
AU  - Dikić, Nenad
AU  - Anđelković, Marija
AU  - Kostić-Vučićević, Marija
AU  - Stojmenović, Tamara
AU  - Nikolić, Ivan
AU  - Đorđević, Brižita
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2753
AB  - A randomized, double-blind, placebo-controlled study was conducted to evaluate if Lactobacillus helveticus Lafti L10 (Lallemand Health Solutions, Montreal, Que., Canada) supplementation during 14 weeks in winter can influence the duration, severity, and incidence of upper respiratory tract illness (URTI), as well as to monitor different immune parameters in the population of elite athletes. Before and after the treatment, cardiopulmonary testing and self-rated state of moods evaluation (by Profile of Mood States questionnaire) were performed and blood samples were collected. Thirty-nine elite athletes were randomized either to the placebo (n = 19) or the probiotic (n = 20) group. The probiotic group received L. helveticus Lafti L10, 2 x 10(10) Colony Forming Units. Lafti L10 significantly shortened the URTI episode duration (7.25 +/- 2.90 vs. 10.64 +/- 4.67 days, p = 0.047) and decreased the number of symptoms in the probiotic group (4.92 +/- 1.96 vs. 6.91 +/- 1.22, p = 0.035). Severity and incidence of URTI did not differ between the treatments. There were no significant changes in leukocyte subpopulation abundance, transforming growth factor-beta serum levels, level of interleukin-10 secreted from peptidoglican stimulated peripheral blood mononuclear cells (PBMCs), interferon-gamma level secreted from concanavalin A-stimulated PBMCs or viability/proliferation of PBMCs upon antigen stimulation. Group effect for CD4+/CD8+ ratio was significant (F-[1,F-37] = 6.99, p = 0.020, eta(2) = 0.350); this difference was not significant at baseline, but was evident after 14 weeks (p = 0.02). A significant interaction effect was noted for self-rated sense of vigor (F-[1,F-37] = 11.76, p = 0.009, eta(2) = 0.595). Self-rated sense of vigor increased in the probiotic group (18.5 +/- 4.1 vs. 21.0 +/- 2.6, p = 0.012). Probiotic strain Lafti L10 can be a beneficial nutritional supplement for the reduction of URTI length in elite athletes.
PB  - Canadian Science Publishing, Nrc Research Press, Ottawa
T2  - Applied Physiology Nutrition and Metabolism
T1  - Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial
VL  - 41
IS  - 7
SP  - 782
EP  - 789
DO  - 10.1139/apnm-2015-0541
ER  - 
@article{
author = "Michalickova, Danica and Minić, Rajna and Dikić, Nenad and Anđelković, Marija and Kostić-Vučićević, Marija and Stojmenović, Tamara and Nikolić, Ivan and Đorđević, Brižita",
year = "2016",
abstract = "A randomized, double-blind, placebo-controlled study was conducted to evaluate if Lactobacillus helveticus Lafti L10 (Lallemand Health Solutions, Montreal, Que., Canada) supplementation during 14 weeks in winter can influence the duration, severity, and incidence of upper respiratory tract illness (URTI), as well as to monitor different immune parameters in the population of elite athletes. Before and after the treatment, cardiopulmonary testing and self-rated state of moods evaluation (by Profile of Mood States questionnaire) were performed and blood samples were collected. Thirty-nine elite athletes were randomized either to the placebo (n = 19) or the probiotic (n = 20) group. The probiotic group received L. helveticus Lafti L10, 2 x 10(10) Colony Forming Units. Lafti L10 significantly shortened the URTI episode duration (7.25 +/- 2.90 vs. 10.64 +/- 4.67 days, p = 0.047) and decreased the number of symptoms in the probiotic group (4.92 +/- 1.96 vs. 6.91 +/- 1.22, p = 0.035). Severity and incidence of URTI did not differ between the treatments. There were no significant changes in leukocyte subpopulation abundance, transforming growth factor-beta serum levels, level of interleukin-10 secreted from peptidoglican stimulated peripheral blood mononuclear cells (PBMCs), interferon-gamma level secreted from concanavalin A-stimulated PBMCs or viability/proliferation of PBMCs upon antigen stimulation. Group effect for CD4+/CD8+ ratio was significant (F-[1,F-37] = 6.99, p = 0.020, eta(2) = 0.350); this difference was not significant at baseline, but was evident after 14 weeks (p = 0.02). A significant interaction effect was noted for self-rated sense of vigor (F-[1,F-37] = 11.76, p = 0.009, eta(2) = 0.595). Self-rated sense of vigor increased in the probiotic group (18.5 +/- 4.1 vs. 21.0 +/- 2.6, p = 0.012). Probiotic strain Lafti L10 can be a beneficial nutritional supplement for the reduction of URTI length in elite athletes.",
publisher = "Canadian Science Publishing, Nrc Research Press, Ottawa",
journal = "Applied Physiology Nutrition and Metabolism",
title = "Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial",
volume = "41",
number = "7",
pages = "782-789",
doi = "10.1139/apnm-2015-0541"
}
Michalickova, D., Minić, R., Dikić, N., Anđelković, M., Kostić-Vučićević, M., Stojmenović, T., Nikolić, I.,& Đorđević, B.. (2016). Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial. in Applied Physiology Nutrition and Metabolism
Canadian Science Publishing, Nrc Research Press, Ottawa., 41(7), 782-789.
https://doi.org/10.1139/apnm-2015-0541
Michalickova D, Minić R, Dikić N, Anđelković M, Kostić-Vučićević M, Stojmenović T, Nikolić I, Đorđević B. Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial. in Applied Physiology Nutrition and Metabolism. 2016;41(7):782-789.
doi:10.1139/apnm-2015-0541 .
Michalickova, Danica, Minić, Rajna, Dikić, Nenad, Anđelković, Marija, Kostić-Vučićević, Marija, Stojmenović, Tamara, Nikolić, Ivan, Đorđević, Brižita, "Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial" in Applied Physiology Nutrition and Metabolism, 41, no. 7 (2016):782-789,
https://doi.org/10.1139/apnm-2015-0541 . .
40
58
36
58

The Effect Of Astaxanthin On Mucosal Immunity, Oxidative Stress And Inflammation In Soccer Players

Đorđević, Brižita; Baralić, Ivana; Anđelković, Marija; Stojmenović, Tamara; Vukašinović-Vesić, Milica; Malić, Tatjana; Marinković, Danica; Dikić, Nenad

(Lippincott Williams & Wilkins, Philadelphia, 2015)

TY  - CONF
AU  - Đorđević, Brižita
AU  - Baralić, Ivana
AU  - Anđelković, Marija
AU  - Stojmenović, Tamara
AU  - Vukašinović-Vesić, Milica
AU  - Malić, Tatjana
AU  - Marinković, Danica
AU  - Dikić, Nenad
PY  - 2015
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2503
PB  - Lippincott Williams & Wilkins, Philadelphia
C3  - Medicine and Science in Sports and Exercise
T1  - The Effect Of Astaxanthin On Mucosal Immunity, Oxidative Stress And Inflammation In Soccer Players
VL  - 47
IS  - 5
SP  - 894
EP  - 894
DO  - 10.1249/01.mss.0000479161.36874.7a
ER  - 
@conference{
author = "Đorđević, Brižita and Baralić, Ivana and Anđelković, Marija and Stojmenović, Tamara and Vukašinović-Vesić, Milica and Malić, Tatjana and Marinković, Danica and Dikić, Nenad",
year = "2015",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Medicine and Science in Sports and Exercise",
title = "The Effect Of Astaxanthin On Mucosal Immunity, Oxidative Stress And Inflammation In Soccer Players",
volume = "47",
number = "5",
pages = "894-894",
doi = "10.1249/01.mss.0000479161.36874.7a"
}
Đorđević, B., Baralić, I., Anđelković, M., Stojmenović, T., Vukašinović-Vesić, M., Malić, T., Marinković, D.,& Dikić, N.. (2015). The Effect Of Astaxanthin On Mucosal Immunity, Oxidative Stress And Inflammation In Soccer Players. in Medicine and Science in Sports and Exercise
Lippincott Williams & Wilkins, Philadelphia., 47(5), 894-894.
https://doi.org/10.1249/01.mss.0000479161.36874.7a
Đorđević B, Baralić I, Anđelković M, Stojmenović T, Vukašinović-Vesić M, Malić T, Marinković D, Dikić N. The Effect Of Astaxanthin On Mucosal Immunity, Oxidative Stress And Inflammation In Soccer Players. in Medicine and Science in Sports and Exercise. 2015;47(5):894-894.
doi:10.1249/01.mss.0000479161.36874.7a .
Đorđević, Brižita, Baralić, Ivana, Anđelković, Marija, Stojmenović, Tamara, Vukašinović-Vesić, Milica, Malić, Tatjana, Marinković, Danica, Dikić, Nenad, "The Effect Of Astaxanthin On Mucosal Immunity, Oxidative Stress And Inflammation In Soccer Players" in Medicine and Science in Sports and Exercise, 47, no. 5 (2015):894-894,
https://doi.org/10.1249/01.mss.0000479161.36874.7a . .

The Impact Of High Risk Situation Announcement On Psychological Stress In Special Unit Forces Members

Baralić, Ivana; Dikić, Nenad; Anđelković, Marija; Mojsilović, Željko; Jeremić-Velimirović, Tanja; Popović, Milka; Vukašinović-Vesić, Milica; Malić, Tatjana; Stojmenović, Tamara; Marinković, Danica; Đorđević, Brižita

(Lippincott Williams & Wilkins, Philadelphia, 2015)

TY  - CONF
AU  - Baralić, Ivana
AU  - Dikić, Nenad
AU  - Anđelković, Marija
AU  - Mojsilović, Željko
AU  - Jeremić-Velimirović, Tanja
AU  - Popović, Milka
AU  - Vukašinović-Vesić, Milica
AU  - Malić, Tatjana
AU  - Stojmenović, Tamara
AU  - Marinković, Danica
AU  - Đorđević, Brižita
PY  - 2015
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2494
PB  - Lippincott Williams & Wilkins, Philadelphia
C3  - Medicine and Science in Sports and Exercise
T1  - The Impact Of High Risk Situation Announcement On Psychological Stress In Special Unit Forces Members
VL  - 47
IS  - 5
SP  - 810
EP  - 810
DO  - 10.1249/01.mss.0000478951.79597.1b
ER  - 
@conference{
author = "Baralić, Ivana and Dikić, Nenad and Anđelković, Marija and Mojsilović, Željko and Jeremić-Velimirović, Tanja and Popović, Milka and Vukašinović-Vesić, Milica and Malić, Tatjana and Stojmenović, Tamara and Marinković, Danica and Đorđević, Brižita",
year = "2015",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Medicine and Science in Sports and Exercise",
title = "The Impact Of High Risk Situation Announcement On Psychological Stress In Special Unit Forces Members",
volume = "47",
number = "5",
pages = "810-810",
doi = "10.1249/01.mss.0000478951.79597.1b"
}
Baralić, I., Dikić, N., Anđelković, M., Mojsilović, Ž., Jeremić-Velimirović, T., Popović, M., Vukašinović-Vesić, M., Malić, T., Stojmenović, T., Marinković, D.,& Đorđević, B.. (2015). The Impact Of High Risk Situation Announcement On Psychological Stress In Special Unit Forces Members. in Medicine and Science in Sports and Exercise
Lippincott Williams & Wilkins, Philadelphia., 47(5), 810-810.
https://doi.org/10.1249/01.mss.0000478951.79597.1b
Baralić I, Dikić N, Anđelković M, Mojsilović Ž, Jeremić-Velimirović T, Popović M, Vukašinović-Vesić M, Malić T, Stojmenović T, Marinković D, Đorđević B. The Impact Of High Risk Situation Announcement On Psychological Stress In Special Unit Forces Members. in Medicine and Science in Sports and Exercise. 2015;47(5):810-810.
doi:10.1249/01.mss.0000478951.79597.1b .
Baralić, Ivana, Dikić, Nenad, Anđelković, Marija, Mojsilović, Željko, Jeremić-Velimirović, Tanja, Popović, Milka, Vukašinović-Vesić, Milica, Malić, Tatjana, Stojmenović, Tamara, Marinković, Danica, Đorđević, Brižita, "The Impact Of High Risk Situation Announcement On Psychological Stress In Special Unit Forces Members" in Medicine and Science in Sports and Exercise, 47, no. 5 (2015):810-810,
https://doi.org/10.1249/01.mss.0000478951.79597.1b . .

Harm Caused By Counterfeit Medicines - The Major Problem In Sport After Doping

Dikić, Nenad; Walser, Sabine; Anđelković, Marija; Jovanović, Zoran; Vukašinović-Vesić, Milica; Đorđević, Brižita; Baralić, Ivana; Stojmenović, Tamara; Malić, Tatjana

(Lippincott Williams & Wilkins, Philadelphia, 2015)

TY  - CONF
AU  - Dikić, Nenad
AU  - Walser, Sabine
AU  - Anđelković, Marija
AU  - Jovanović, Zoran
AU  - Vukašinović-Vesić, Milica
AU  - Đorđević, Brižita
AU  - Baralić, Ivana
AU  - Stojmenović, Tamara
AU  - Malić, Tatjana
PY  - 2015
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2491
PB  - Lippincott Williams & Wilkins, Philadelphia
C3  - Medicine and Science in Sports and Exercise
T1  - Harm Caused By Counterfeit Medicines - The Major Problem In Sport After Doping
VL  - 47
IS  - 5
SP  - 760
EP  - 760
DO  - 10.1249/01.mss.0000478811.21279.eb
ER  - 
@conference{
author = "Dikić, Nenad and Walser, Sabine and Anđelković, Marija and Jovanović, Zoran and Vukašinović-Vesić, Milica and Đorđević, Brižita and Baralić, Ivana and Stojmenović, Tamara and Malić, Tatjana",
year = "2015",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Medicine and Science in Sports and Exercise",
title = "Harm Caused By Counterfeit Medicines - The Major Problem In Sport After Doping",
volume = "47",
number = "5",
pages = "760-760",
doi = "10.1249/01.mss.0000478811.21279.eb"
}
Dikić, N., Walser, S., Anđelković, M., Jovanović, Z., Vukašinović-Vesić, M., Đorđević, B., Baralić, I., Stojmenović, T.,& Malić, T.. (2015). Harm Caused By Counterfeit Medicines - The Major Problem In Sport After Doping. in Medicine and Science in Sports and Exercise
Lippincott Williams & Wilkins, Philadelphia., 47(5), 760-760.
https://doi.org/10.1249/01.mss.0000478811.21279.eb
Dikić N, Walser S, Anđelković M, Jovanović Z, Vukašinović-Vesić M, Đorđević B, Baralić I, Stojmenović T, Malić T. Harm Caused By Counterfeit Medicines - The Major Problem In Sport After Doping. in Medicine and Science in Sports and Exercise. 2015;47(5):760-760.
doi:10.1249/01.mss.0000478811.21279.eb .
Dikić, Nenad, Walser, Sabine, Anđelković, Marija, Jovanović, Zoran, Vukašinović-Vesić, Milica, Đorđević, Brižita, Baralić, Ivana, Stojmenović, Tamara, Malić, Tatjana, "Harm Caused By Counterfeit Medicines - The Major Problem In Sport After Doping" in Medicine and Science in Sports and Exercise, 47, no. 5 (2015):760-760,
https://doi.org/10.1249/01.mss.0000478811.21279.eb . .

Pre-Game And Post-Game Hydration Status Of Young Basketball Players

Vukašinović-Vesić, Milica; Anđelković, Marija; Dikić, Nenad; Baralić, Ivana; Stojmenović, Tamara; Malić, Tatjana; Đorđević, Brižita

(Lippincott Williams & Wilkins, Philadelphia, 2015)

TY  - CONF
AU  - Vukašinović-Vesić, Milica
AU  - Anđelković, Marija
AU  - Dikić, Nenad
AU  - Baralić, Ivana
AU  - Stojmenović, Tamara
AU  - Malić, Tatjana
AU  - Đorđević, Brižita
PY  - 2015
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2489
PB  - Lippincott Williams & Wilkins, Philadelphia
C3  - Medicine and Science in Sports and Exercise
T1  - Pre-Game And Post-Game Hydration Status Of Young Basketball Players
VL  - 47
IS  - 5
SP  - 503
EP  - 504
DO  - 10.1249/01.mss.0000477817.33697.4f
ER  - 
@conference{
author = "Vukašinović-Vesić, Milica and Anđelković, Marija and Dikić, Nenad and Baralić, Ivana and Stojmenović, Tamara and Malić, Tatjana and Đorđević, Brižita",
year = "2015",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Medicine and Science in Sports and Exercise",
title = "Pre-Game And Post-Game Hydration Status Of Young Basketball Players",
volume = "47",
number = "5",
pages = "503-504",
doi = "10.1249/01.mss.0000477817.33697.4f"
}
Vukašinović-Vesić, M., Anđelković, M., Dikić, N., Baralić, I., Stojmenović, T., Malić, T.,& Đorđević, B.. (2015). Pre-Game And Post-Game Hydration Status Of Young Basketball Players. in Medicine and Science in Sports and Exercise
Lippincott Williams & Wilkins, Philadelphia., 47(5), 503-504.
https://doi.org/10.1249/01.mss.0000477817.33697.4f
Vukašinović-Vesić M, Anđelković M, Dikić N, Baralić I, Stojmenović T, Malić T, Đorđević B. Pre-Game And Post-Game Hydration Status Of Young Basketball Players. in Medicine and Science in Sports and Exercise. 2015;47(5):503-504.
doi:10.1249/01.mss.0000477817.33697.4f .
Vukašinović-Vesić, Milica, Anđelković, Marija, Dikić, Nenad, Baralić, Ivana, Stojmenović, Tamara, Malić, Tatjana, Đorđević, Brižita, "Pre-Game And Post-Game Hydration Status Of Young Basketball Players" in Medicine and Science in Sports and Exercise, 47, no. 5 (2015):503-504,
https://doi.org/10.1249/01.mss.0000477817.33697.4f . .